Evidence map›Paper›PMID 30206218›Full record

ArticleNature communications2018

Reviving the Weizmann process for commercial n-butanol production.

Ngoc-Phuong-Thao Nguyen, Céline Raynaud, Isabelle Meynial-Salles, Philippe Soucaille

Abstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. EngineeringACS synthetic biology · 2026
    Article
  2. Article
  3. Comparative Metabolomics ofJournal of microbiology and biotechnology · 2025
    Article
  4. Toxic Effects of Butanol in the Plane of the Cell Membrane.Langmuir : the ACS journal of surfaces and colloids · 2025
    Article
  5. Article
  6. Article
  7. The potential of native and engineered Clostridia for biomass biorefining.Frontiers in bioengineering and biotechnology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Chromosomal engineering of inducible isopropanol- butanol-ethanol production inFrontiers in bioengineering and biotechnology · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Genome Sequence ofMicroorganisms · 2022
    Article
  18. Article
  19. EstablishingApplied and environmental microbiology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ngoc-Phuong-Thao NguyenINSA, UPS, INP, LISBP, Université de Toulouse, Toulouse, France.
Céline RaynaudMetabolic Explorer, Biopôle Clermont-Limagne, Saint Beauzire, France.
Isabelle Meynial-SallesINSA, UPS, INP, LISBP, Université de Toulouse, Toulouse, France.
Philippe SoucailleINSA, UPS, INP, LISBP, Université de Toulouse, Toulouse, France. soucaille@insa-toulouse.fr.

Funding

European Commission (EC) PEOPLE-ITN-2008-237942
6 · The paper itself

Abstract

Developing a commercial process for the biological production of n-butanol is challenging as it needs to combine high titer, yield, and productivities. Here we engineer Clostridium acetobutylicum to stably and continuously produce n-butanol on a mineral media with glucose as sole carbon source. We further design a continuous process for fermentation of high concentration glucose syrup using in situ extraction of alcohols by distillation under low pressure and high cell density cultures to increase the titer, yield, and productivity of n-butanol production to the level of 550 g/L, 0.35 g/g, and 14 g/L/hr, respectively. This process provides a mean to produce n-butanol at performance levels comparable to that of corn wet milling ethanol plants using yeast as a biocatalyst. It may hold the potential to be scaled-up at pilot and industrial levels for the commercial production of n-butanol.

Identifiers

PMID30206218
PMCPMC6134114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.